NCT03487393

Brief Summary

Find the stimulation threshold of the facial nerve (ganglion Geniculate) associated with tolerability and safety in subjects Healthy humans.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 19, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2015

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2016

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

June 17, 2017

Completed
10 months until next milestone

First Posted

Study publicly available on registry

April 4, 2018

Completed
Last Updated

April 4, 2018

Status Verified

March 1, 2018

Enrollment Period

2 months

First QC Date

June 17, 2017

Last Update Submit

March 27, 2018

Conditions

Keywords

facial nervemagnetic stimulationcerebral blood flow

Outcome Measures

Primary Outcomes (1)

  • Change in perfusion index of cerebral blood flow

    An algorithm to calculate the perfusion index using magnetic resonance images across the entire brain

    10 minutes post-stimulation

Study Arms (1)

Vitalflow treatment

EXPERIMENTAL

The subject's exposure will be through a ramp model of increments in magnetic stimulation power delivered to the facial nerves bilaterally. Increases in magnetic stimulation will be 10% for 10 seconds from 10% to 60%. Subsequent to this will be evaluated for 5 minutes in the power of tolerability of the subject (60% 70%, 80% or 90%).

Device: magnetic facial nerve stimulation

Interventions

Magnetic stimulation of facial nerve.

Vitalflow treatment

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy subjects

You may not qualify if:

  • Subjects with a diagnosis of epilepsy, seizures, facial nerve palsy, migraine or recurrent headaches, glaucoma or neuropathies.
  • Subjects in breastfeeding or in pregnancy. (To be confirmed with test strip).
  • Subjects with acute or acute chronic medical conditions.
  • Age less than 20 years or greater than 40 years.
  • Carotid surgery.
  • Episodes of syncope.
  • Known arteriosclerosis anywhere on the body
  • Metal implants (cochlear implants, pacemakers, metal prostheses).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Nacional de Investigación en Imagenología e Instrumentación Medica

Mexico City, Mexico City, 09340, Mexico

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Prospective
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2017

First Posted

April 4, 2018

Study Start

October 19, 2015

Primary Completion

December 15, 2015

Study Completion

January 8, 2016

Last Updated

April 4, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will share

available from investigators authors upon reasonable request

Locations